Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

An international perspective on hospitalized patients with viral community-acquired pneumonia.

Radovanovic D, Sotgiu G, Jankovic M, Mahesh PA, Marcos PJ, Abdalla MI, Di Pasquale MF, Gramegna A, Terraneo S, Blasi F, Santus P, Aliberti S, Reyes LF, Restrepo MI; GLIMP Study Group, Aruj PK, Attorri S, Barimboim E, Caeiro JP, Garzón MI, Cambursano VH, Ceccato A, Chertcoff J, Cordon Díaz A, de Vedia L, Ganaha MC, Lambert S, Lopardo G, Luna CM, Malberti AG, Morcillo N, Tartara S, Pensotti C, Pereyra B, Scapellato PG, Stagnaro JP, Shah S, Lötsch F, Thalhammer F, Anseeuw K, Francois CA, Van Braeckel E, Vincent JL, Djimon MZ, Aranha Nouér S, Chipev P, Encheva M, Miteva D, Petkova D, Balkissou AD, Pefura Yone EW, Mbatchou Ngahane BH, Shen N, Xu JF, Bustamante Rico CA, Buitrago R, Pereira Paternina FJ, Kayembe Ntumba JM, Vladic-Carevic V, Jakopovic M, Matkovic Z, Mitrecic I, Bouchy Jacobsson ML, Bro Christensen A, Heitmann Bødtger UC, Meyer CN, Vestergaard Jensen A, El-Said Abd El-Wahhab I, Elsayed Morsy N, Shafiek H, Sobh E, Abdulsemed KA, Bertrand F, Brun-Buisson C, de Montmollin E, Fartoukh M, Messika J, Tattevin P, Khoury A, Ebruke B, Dreher M, Kolditz M, Meisinger M, Pletz MW, Hagel S, Rupp J, Schaberg T, Spielmanns M, Creutz P, Suttorp N, Siaw-Lartey B, Dimakou K, Papapetrou D, Tsigou E, Ampazis D, Kaimakamis E, Bhatia M, Dhar R, D'Souza G, Garg R, Koul PA, Jayaraj BS, Narayan KV, Udnur HB, Krishnamurthy SB, Kant S, Swarnakar R, Salvi S, Limaye S, Golshani K, Keatings VM, Martin-Loeches I, Maor Y, Strahilevitz J, Battaglia S, Carrabba M, Ceriana P, Confalonieri M, d'Arminio Monforte A, Del Prato B, De Rosa M, Fantini R, Fiorentino G, Gammino MA, Menzella F, Milani G, Nava S, Palmiero G, Petrino R, Gabrielli B, Rossi P, Sorino C, Steinhilber G, Zanforlin A, Franzetti F, Carone M, Patella V, Scarlata S, Comel A, Kurahashi K, Aoun Bacha Z, Barajas Ugalde D, Ceballos Zuñiga O, Villegas JF, Medenica M, van de Garde EMW, Raj Mihsra D, Shrestha P, Ridgeon E, Ishola Awokola B, Nwankwo ONO, Olufunlola AB, Olumide S, Ukwaja KN, Irfan M, Minarowski L, Szymon S, Froes F, Leuschner P, Meireles M, Ferrão C, Leuschner P, Neves J, Ravara SB, Brocovschii V, Ion C, Rusu D, Toma C, Chirita D, Dorobat CM, Birkun A, Kaluzhenina A, Almotairi A, Bukhary ZAA, Edathodu J, Fathy A, Mushira Abdulaziz Enani A, Eltayeb Mohamed N, Ulhadi Memon J, Bella A, Bogdanović N, Milenkovic B, Pesut D, Borderìas L, Bordon Garcia NM, Cabello Alarcón H, Cilloniz C, Torres A, Diaz-Brito V, Casas X, Encabo González A, Fernández-Almira ML, Gallego M, Gaspar-GarcÍa I, González Del Castillo J, Javaloyes Victoria P, Laserna Martínez E, Malo de Molina R, Menéndez R, Pando-Sandoval A, Prat Aymerich C, Lacoma de la Torre A, García-Olivé I, Rello J, Moyano S, Sanz F, Sibila O, Rodrigo-Troyano A, Solé-Violán J, Uranga A, van Boven JFM, Vendrell Torra E, Pujol JA, Feldman C, Kee Yum H, Fiogbe AA, Yangui F, Bilaceroglu S, Dalar L, Yilmaz U, Bogomolov A, Elahi N, Dhasmana DJ, Feneley A, Hancock C, Hill AT, Rudran B, Ruiz-Buitrago S, Campbell M, Whitaker P, Youzguin A, Singanayagam A, Allen KS, Brito V, Dietz J, Dysart CE, Kellie SM, Franco-Sadud RA, Meier G, Gaga M, Holland TL, Bergin SP, Kheir F, Landmeier M, Lois M, Nair GB, Patel H, Reyes K, Rodriguez-Cintron W, Saito S, Soni NJ, Noda J, Hinojosa CI, Levine SM, Angel LF, Anzueto A, Scott Whitlow K, Hipskind J, Sukhija K, Totten V, Wunderink RG, Shah RD, Mateyo KJ, Carugati M, Morosi M, Monge E.

Eur J Intern Med. 2018 Nov 3. pii: S0953-6205(18)30413-8. doi: 10.1016/j.ejim.2018.10.020. [Epub ahead of print]

PMID:
30401576
2.

Treatable traits in bronchiectasis.

Boaventura R, Sibila O, Agusti A, Chalmers JD.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801269. doi: 10.1183/13993003.01269-2018. Print 2018 Sep. No abstract available.

PMID:
30190263
3.

Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study.

Rodrigo-Troyano A, Melo V, Marcos PJ, Laserna E, Peiro M, Suarez-Cuartin G, Perea L, Feliu A, Plaza V, Faverio P, Restrepo MI, Anzueto A, Sibila O.

Respiration. 2018;96(5):417-424. doi: 10.1159/000490190. Epub 2018 Jul 24.

PMID:
30041176
4.

Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients.

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S; GLIMP.

Eur Respir J. 2018 Aug 9;52(2). pii: 1701190. doi: 10.1183/13993003.01190-2017. Print 2018 Aug.

PMID:
29976651
5.

Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.

Restrepo MI, Sibila O, Anzueto A.

Tuberc Respir Dis (Seoul). 2018 Jul;81(3):187-197. doi: 10.4046/trd.2018.0030. Review.

6.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
7.

Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: do we need a personalized approach?

Paolini V, Faverio P, Aliberti S, Messinesi G, Foti G, Sibila O, Monzani A, De Giacomi F, Stainer A, Pesci A.

PeerJ. 2018 Jan 30;6:e4211. doi: 10.7717/peerj.4211. eCollection 2018.

8.

Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood.

Crespo-Lessmann A, Mateus E, Torrejón M, Belda A, Giner J, Vidal S, Sibila O, Plaza V.

J Asthma Allergy. 2017 Oct 12;10:269-276. doi: 10.2147/JAA.S142200. eCollection 2017.

9.

The respiratory threat posed by multidrug resistant Gram-negative bacteria.

Rodrigo-Troyano A, Sibila O.

Respirology. 2017 Oct;22(7):1288-1299. doi: 10.1111/resp.13115. Epub 2017 Jul 6. Review.

10.

High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis.

Mangat M, Amalakuhan B, Habib S, Reyes LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer GW, Martin-Loeches I, Blanquer J, Sanz F, Marcos PJ, Solé-Violán J, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orihuela CJ, Restrepo MI.

Eur Respir J. 2017 Jul 5;50(1). pii: 1700013. doi: 10.1183/13993003.00013-2017. Print 2017 Jul. No abstract available.

PMID:
28679609
11.

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

Ceccato A, Cilloniz C, Ranzani OT, Menendez R, Agusti C, Gabarrus A, Ferrer M, Sibila O, Niederman MS, Torres A.

PLoS One. 2017 Jun 15;12(6):e0178022. doi: 10.1371/journal.pone.0178022. eCollection 2017.

12.

Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Reyes LF, Restrepo MI, Hinojosa CA, Soni NJ, Anzueto A, Babu BL, Gonzalez-Juarbe N, Rodriguez AH, Jimenez A, Chalmers JD, Aliberti S, Sibila O, Winter VT, Coalson JJ, Giavedoni LD, Dela Cruz CS, Waterer GW, Witzenrath M, Suttorp N, Dube PH, Orihuela CJ.

Am J Respir Crit Care Med. 2017 Sep 1;196(5):609-620. doi: 10.1164/rccm.201701-0104OC.

13.

Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis.

Suarez-Cuartin G, Smith A, Abo-Leyah H, Rodrigo-Troyano A, Perea L, Vidal S, Plaza V, Fardon TC, Sibila O, Chalmers JD.

Respir Med. 2017 Jul;128:1-6. doi: 10.1016/j.rmed.2017.05.001. Epub 2017 May 2.

PMID:
28610665
14.

Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.

Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, Furrie E, Fong CJ, Ibrahim W, Brady G, Einarsson GG, Elborn JS, Schembri S, Marshall SE, Palmer CNA, Chalmers JD.

J Allergy Clin Immunol. 2018 Jan;141(1):117-127. doi: 10.1016/j.jaci.2017.04.022. Epub 2017 May 13.

15.

The microbiome in respiratory medicine: current challenges and future perspectives.

Faner R, Sibila O, Agustí A, Bernasconi E, Chalmers JD, Huffnagle GB, Manichanh C, Molyneaux PL, Paredes R, Pérez Brocal V, Ponomarenko J, Sethi S, Dorca J, Monsó E.

Eur Respir J. 2017 Apr 12;49(4). pii: 1602086. doi: 10.1183/13993003.02086-2016. Print 2017 Apr. Review.

16.

Relationship Between Severity Classification of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Clinical Outcomes in Hospitalized Patients.

Marcos PJ, Sanjuán P, Huerta A, Nieto-Codesido I, Ferreira-Gonzalez L, Sibila O, Restrepo MI.

Cureus. 2017 Jan 22;9(1):e988. doi: 10.7759/cureus.988.

17.

New biomarkers in community-acquired pneumonia: Another step in improving outcome prediction.

Faverio P, Sibila O.

Respirology. 2017 Apr;22(3):416-417. doi: 10.1111/resp.13003. Epub 2017 Feb 16. No abstract available.

PMID:
28206691
18.

Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

Sibila O, Rodrigo-Troyano A, Torres A.

Semin Respir Crit Care Med. 2016 Dec;37(6):913-922. Epub 2016 Dec 13. Review.

PMID:
27960215
19.

Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis.

Chalmers JD, Moffitt KL, Suarez-Cuartin G, Sibila O, Finch S, Furrie E, Dicker A, Wrobel K, Elborn JS, Walker B, Martin SL, Marshall SE, Huang JT, Fardon TC.

Am J Respir Crit Care Med. 2017 May 15;195(10):1384-1393. doi: 10.1164/rccm.201605-1027OC.

20.

Reply: Measuring Airway Mucin 2 in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.

Sibila O, Mateus EF, Restrepo MI, Chalmers JD, Vidal S.

Ann Am Thorac Soc. 2016 Nov;13(11):2104-2105. No abstract available.

PMID:
27831804
21.

Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis.

Amalakuhan B, Habib SA, Mangat M, Reyes LF, Rodriguez AH, Hinojosa CA, Soni NJ, Gilley RP, Bustamante CA, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Chalmers JD, Torres A, Waterer GW, Martin-Loeches I, Bordon J, Blanquer J, Sanz F, Marcos PJ, Rello J, Ramirez J, Solé-Violán J, Luna CM, Feldman C, Witzenrath M, Wunderink RG, Stolz D, Wiemken TL, Shindo Y, Dela Cruz CS, Orihuela CJ, Restrepo MI.

Cytokine. 2016 Dec;88:267-273. doi: 10.1016/j.cyto.2016.08.028. Epub 2016 Oct 1.

22.

Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD.

Rodrigo-Troyano A, Suarez-Cuartin G, Peiró M, Barril S, Castillo D, Sanchez-Reus F, Plaza V, Restrepo MI, Chalmers JD, Sibila O.

Respirology. 2016 Oct;21(7):1235-42. doi: 10.1111/resp.12825. Epub 2016 Jun 20.

PMID:
27325555
23.

Diagnostic challenges of bronchiectasis.

Suarez-Cuartin G, Chalmers JD, Sibila O.

Respir Med. 2016 Jul;116:70-7. doi: 10.1016/j.rmed.2016.05.014. Epub 2016 May 17. Review.

24.

Oral Low-dose Theophylline on Top of Inhaled Fluticasone-Salmeterol Does Not Reduce Exacerbations in Patients With Severe COPD: A Pilot Clinical Trial.

Cosío BG, Shafiek H, Iglesias A, Yanez A, Córdova R, Palou A, Rodriguez-Roisin R, Peces-Barba G, Pascual S, Gea J, Sibila O, Barnes PJ, Agusti A.

Chest. 2016 Jul;150(1):123-30. doi: 10.1016/j.chest.2016.04.011. Epub 2016 Apr 21.

PMID:
27107490
25.

Multidrug-resistant pathogens in patients with pneumonia coming from the community.

Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, Restrepo MI.

Curr Opin Pulm Med. 2016 May;22(3):219-26. doi: 10.1097/MCP.0000000000000263. Review.

PMID:
26960007
26.

Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.

Sibila O, Garcia-Bellmunt L, Giner J, Rodrigo-Troyano A, Suarez-Cuartin G, Torrego A, Castillo D, Solanes I, Mateus EF, Vidal S, Sanchez-Reus F, Sala E, Cosio BG, Restrepo MI, Anzueto A, Chalmers JD, Plaza V.

Ann Am Thorac Soc. 2016 May;13(5):636-42. doi: 10.1513/AnnalsATS.201512-797OC.

27.

Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer.

Plaza V, Crespo A, Giner J, Merino JL, Ramos-Barbón D, Mateus EF, Torrego A, Cosio BG, Agustí A, Sibila O.

J Investig Allergol Clin Immunol. 2015;25(6):431-7.

28.

Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations.

Shafiek H, Fiorentino F, Merino JL, López C, Oliver A, Segura J, de Paul I, Sibila O, Agustí A, Cosío BG.

PLoS One. 2015 Sep 9;10(9):e0135199. doi: 10.1371/journal.pone.0135199. eCollection 2015.

29.

Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.

Sibila O, Suarez-Cuartin G, Rodrigo-Troyano A, Fardon TC, Finch S, Mateus EF, Garcia-Bellmunt L, Castillo D, Vidal S, Sanchez-Reus F, Restrepo MI, Chalmers JD.

Respirology. 2015 Oct;20(7):1082-8. doi: 10.1111/resp.12595. Epub 2015 Jul 14.

30.

Chromogranin A levels and mortality in patients with severe sepsis.

Hsu CH, Reyes LF, Orihuela CJ, Buitrago R, Anzueto A, Soni NJ, Levine S, Peters J, Hinojosa CA, Aliberti S, Sibila O, Rodriguez A, Chalmers JD, Martin-Loeches I, Bordon J, Blanquer J, Sanz F, Marcos PJ, Rello J, Solé-Violán J, Restrepo MI.

Biomarkers. 2015;20(3):171-6. doi: 10.3109/1354750X.2015.1046932. Epub 2015 Jul 8.

31.

The risk and outcomes of pneumonia in patients on inhaled corticosteroids.

Sibila O, Soto-Gomez N, Restrepo MI.

Pulm Pharmacol Ther. 2015 Jun;32:130-6. doi: 10.1016/j.pupt.2015.04.001. Epub 2015 May 5. Review.

32.

Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.

Sibila O, Laserna E, Maselli DJ, Fernandez JF, Mortensen EM, Anzueto A, Waterer G, Restrepo MI.

Respirology. 2015 May;20(4):660-6. doi: 10.1111/resp.12506. Epub 2015 Mar 16.

33.

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C.

JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015.88.

34.

Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Agustí A, Antó JM, Auffray C, Barbé F, Barreiro E, Dorca J, Escarrabill J, Faner R, Furlong LI, Garcia-Aymerich J, Gea J, Lindmark B, Monsó E, Plaza V, Puhan MA, Roca J, Ruiz-Manzano J, Sampietro-Colom L, Sanz F, Serrano L, Sharpe J, Sibila O, Silverman EK, Sterk PJ, Sznajder JI.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):391-401. doi: 10.1164/rccm.201410-1935PP.

35.

Migratory pulmonary nodules in a patient with ulcerative colitis.

Barril S, Rodrigo-Troyano A, Giménez A, Sibila O.

Arch Bronconeumol. 2015 Jun;51(6):303-4. doi: 10.1016/j.arbres.2014.07.006. Epub 2014 Sep 30. English, Spanish. No abstract available.

36.

Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.

Sibila O, Garcia-Bellmunt L, Giner J, Merino JL, Suarez-Cuartin G, Torrego A, Solanes I, Castillo D, Valera JL, Cosio BG, Plaza V, Agusti A.

Respir Med. 2014 Nov;108(11):1608-14. doi: 10.1016/j.rmed.2014.09.008. Epub 2014 Sep 19.

37.

Predicting treatment failure in patients with community acquired pneumonia: a case-control study.

Martin-Loeches I, Valles X, Menendez R, Sibila O, Montull B, Cilloniz C, Artigas A, Torres A.

Respir Res. 2014 Jul 5;15:75. doi: 10.1186/1465-9921-15-75.

38.

Corticosteroids as adjunctive treatment in community-acquired pneumonia.

Sibila O, Ferrer M, Agustí C, Torres A.

Minerva Anestesiol. 2014 Dec;80(12):1336-44. Epub 2014 Feb 11. Review.

39.

Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.

Laserna E, Sibila O, Fernandez JF, Maselli DJ, Mortensen EM, Anzueto A, Waterer G, Restrepo MI.

Chest. 2014 May;145(5):1114-1120. doi: 10.1378/chest.13-1607.

40.

THE PARADOXICAL EFFECT ON PNEUMONIA OF CHRONIC INHALED CORTICOSTEROIDS.

Sibila O, Anzueto A, Restrepo MI.

Clin Pulm Med. 2013 Jan 1;20(1). doi: 10.1097/CPM.0b013e31827a2a60.

41.

The first tissue-engineered airway transplantation: 5-year follow-up results.

Gonfiotti A, Jaus MO, Barale D, Baiguera S, Comin C, Lavorini F, Fontana G, Sibila O, Rombolà G, Jungebluth P, Macchiarini P.

Lancet. 2014 Jan 18;383(9913):238-44. doi: 10.1016/S0140-6736(13)62033-4. Epub 2013 Oct 23.

PMID:
24161821
42.

Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.

Sibila O, Mortensen EM, Anzueto A, Laserna E, Restrepo MI.

Eur Respir J. 2014 Jan;43(1):36-42. doi: 10.1183/09031936.00117312. Epub 2013 Apr 18.

43.

What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents).

Sibila O, Restrepo MI, Anzueto A.

Infect Dis Clin North Am. 2013 Mar;27(1):133-47. doi: 10.1016/j.idc.2012.11.014. Epub 2012 Dec 21. Review.

PMID:
23398870
44.

Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.

Sibila O, Laserna E, Mortensen EM, Anzueto A, Restrepo MI.

Respir Care. 2013 Sep;58(9):1489-94. doi: 10.4187/respcare.02191. Epub 2013 Jan 23.

45.

Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.

Sibila O, Meduri GU, Mortensen EM, Anzueto A, Laserna E, Fernandez JF, El-Sohl A, Restrepo MI.

J Crit Care. 2013 Jun;28(3):284-90. doi: 10.1016/j.jcrc.2012.09.010. Epub 2012 Dec 21.

46.

Impact of prior systemic corticosteroid use in patients admitted with community-acquired pneumonia.

Malave A, Laserna E, Sibila O, Mortensen EM, Anzueto A, Restrepo MI.

Ther Adv Respir Dis. 2012 Dec;6(6):323-30. doi: 10.1177/1753465812458985.

PMID:
23179232
47.

Corticosteroids for pneumonia: are we there yet?

Sibila O, Restrepo MI.

Respirology. 2013 Feb;18(2):199-200. doi: 10.1111/resp.12012. No abstract available.

48.

Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.

Fernandez JF, Sibila O, Restrepo MI.

Expert Rev Clin Pharmacol. 2012 Jul;5(4):445-58. doi: 10.1586/ecp.12.28. Review.

PMID:
22943124
49.

Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia.

Laserna E, Sibila O, Aguilar PR, Mortensen EM, Anzueto A, Blanquer JM, Sanz F, Rello J, Marcos PJ, Velez MI, Aziz N, Restrepo MI.

Chest. 2012 Nov;142(5):1193-1199. doi: 10.1378/chest.12-0576.

50.

Pulmonary nocardiosis in patients with COPD: characteristics and prognostic factors.

Garcia-Bellmunt L, Sibila O, Solanes I, Sanchez-Reus F, Plaza V.

Arch Bronconeumol. 2012 Aug;48(8):280-5. doi: 10.1016/j.arbres.2012.04.009. Epub 2012 May 30. English, Spanish.

Supplemental Content

Loading ...
Support Center